Literature DB >> 23447672

A complex containing LPP and α-actinin mediates TGFβ-induced migration and invasion of ErbB2-expressing breast cancer cells.

Elaine Ngan1, Jason J Northey, Claire M Brown, Josie Ursini-Siegel, Peter M Siegel.   

Abstract

Transforming growth factor β (TGFβ) is a potent modifier of the malignant phenotype in ErbB2-expressing breast cancers. We demonstrate that epithelial-derived breast cancer cells, which undergo a TGFβ-induced epithelial-to-mesenchymal transition (EMT), engage signaling molecules that normally facilitate cellular migration and invasion of mesenchymal cells. We identify lipoma preferred partner (LPP) as an indispensable regulator of TGFβ-induced migration and invasion of ErbB2-expressing breast cancer cells. We show that LPP re-localizes to focal adhesion complexes upon TGFβ stimulation and is a critical determinant in TGFβ-mediated focal adhesion turnover. Finally, we have determined that the interaction between LPP and α-actinin, an actin cross-linking protein, is necessary for TGFβ-induced migration and invasion of ErbB2-expressing breast cancer cells. Thus, our data reveal that LPP, which is normally operative in cells of mesenchymal origin, can be co-opted by breast cancer cells during an EMT to promote their migration and invasion.

Entities:  

Keywords:  Breast cancer; EMT; ErbB2; Invasion; LPP; Migration; TGFβ

Mesh:

Substances:

Year:  2013        PMID: 23447672      PMCID: PMC3791827          DOI: 10.1242/jcs.118315

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  80 in total

1.  The lipoma preferred partner LPP interacts with alpha-actinin.

Authors:  Bo Li; Lei Zhuang; Matthias Reinhard; Beat Trueb
Journal:  J Cell Sci       Date:  2003-04-01       Impact factor: 5.285

Review 2.  ErbB/EGF signaling and EMT in mammary development and breast cancer.

Authors:  Katharine M Hardy; Brian W Booth; Mary J C Hendrix; David S Salomon; Luigi Strizzi
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-04-06       Impact factor: 2.673

3.  Conditional overexpression of active transforming growth factor beta1 in vivo accelerates metastases of transgenic mammary tumors.

Authors:  Rebecca S Muraoka-Cook; Hirokazu Kurokawa; Yasuhiro Koh; James T Forbes; L Renee Roebuck; Mary Helen Barcellos-Hoff; Susan E Moody; Lewis A Chodosh; Carlos L Arteaga
Journal:  Cancer Res       Date:  2004-12-15       Impact factor: 12.701

4.  Cooperation of the ErbB2 receptor and transforming growth factor beta in induction of migration and invasion in mammary epithelial cells.

Authors:  Sarah E Seton-Rogers; Yu Lu; Lisa M Hines; Malvika Koundinya; Joshua LaBaer; Senthil K Muthuswamy; Joan S Brugge
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-22       Impact factor: 11.205

5.  Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases.

Authors:  Rebecca S Muraoka; Nancy Dumont; Christoph A Ritter; Teresa C Dugger; Dana M Brantley; Jin Chen; Evangeline Easterly; L Renee Roebuck; Sarah Ryan; Philip J Gotwals; Victor Koteliansky; Carlos L Arteaga
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

6.  A role for MEK kinase 1 in TGF-beta/activin-induced epithelium movement and embryonic eyelid closure.

Authors:  Lin Zhang; Wei Wang; Yasuhito Hayashi; James V Jester; David E Birk; Min Gao; Chia-Yang Liu; Winston W-Y Kao; Michael Karin; Ying Xia
Journal:  EMBO J       Date:  2003-09-01       Impact factor: 11.598

Review 7.  TGF-beta signaling: a tale of two responses.

Authors:  Rod A Rahimi; Edward B Leof
Journal:  J Cell Biochem       Date:  2007-10-15       Impact factor: 4.429

8.  Overexpression of HER2 (erbB2) in human breast epithelial cells unmasks transforming growth factor beta-induced cell motility.

Authors:  Yukiko Ueda; Shizhen Wang; Nancy Dumont; Jae Youn Yi; Yasuhiro Koh; Carlos L Arteaga
Journal:  J Biol Chem       Date:  2004-03-24       Impact factor: 5.157

9.  Transforming growth factor-β-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression.

Authors:  M K Wendt; J A Smith; W P Schiemann
Journal:  Oncogene       Date:  2010-08-30       Impact factor: 9.867

10.  Beta3 integrin and Src facilitate transforming growth factor-beta mediated induction of epithelial-mesenchymal transition in mammary epithelial cells.

Authors:  Amy J Galliher; William P Schiemann
Journal:  Breast Cancer Res       Date:  2006       Impact factor: 6.466

View more
  25 in total

1.  Transposon mutagenesis identifies genes and cellular processes driving epithelial-mesenchymal transition in hepatocellular carcinoma.

Authors:  Takahiro Kodama; Justin Y Newberg; Michiko Kodama; Roberto Rangel; Kosuke Yoshihara; Jean C Tien; Pamela H Parsons; Hao Wu; Milton J Finegold; Neal G Copeland; Nancy A Jenkins
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-31       Impact factor: 11.205

2.  Distinct splice variants and pathway enrichment in the cell-line models of aggressive human breast cancer subtypes.

Authors:  Rajasree Menon; Hogune Im; Emma Yue Zhang; Shiaw-Lin Wu; Rui Chen; Michael Snyder; William S Hancock; Gilbert S Omenn
Journal:  J Proteome Res       Date:  2013-11-07       Impact factor: 4.466

3.  High Throughput Traction Force Microscopy Using PDMS Reveals Dose-Dependent Effects of Transforming Growth Factor-β on the Epithelial-to-Mesenchymal Transition.

Authors:  Haruka Yoshie; Newsha Koushki; Clayton Molter; Peter M Siegel; Ramaswamy Krishnan; Allen J Ehrlicher
Journal:  J Vis Exp       Date:  2019-06-01       Impact factor: 1.355

4.  GPNMB cooperates with neuropilin-1 to promote mammary tumor growth and engages integrin α5β1 for efficient breast cancer metastasis.

Authors:  G Maric; M G Annis; Z Dong; A A N Rose; S Ng; D Perkins; P A MacDonald; V Ouellet; C Russo; P M Siegel
Journal:  Oncogene       Date:  2015-03-16       Impact factor: 9.867

5.  Cell monolayer deformation microscopy reveals mechanical fragility of cell monolayers following EMT.

Authors:  Amy A Sutton; Clayton W Molter; Ali Amini; Johanan Idicula; Max Furman; Pouria Tirgar; Yuanyuan Tao; Ajinkya Ghagre; Newsha Koushki; Adele Khavari; Allen J Ehrlicher
Journal:  Biophys J       Date:  2022-01-06       Impact factor: 4.033

6.  The SHCA adapter protein cooperates with lipoma-preferred partner in the regulation of adhesion dynamics and invadopodia formation.

Authors:  Alex Kiepas; Elena Voorand; Julien Senecal; Ryuhjin Ahn; Matthew G Annis; Kévin Jacquet; George Tali; Nicolas Bisson; Josie Ursini-Siegel; Peter M Siegel; Claire M Brown
Journal:  J Biol Chem       Date:  2020-04-16       Impact factor: 5.157

7.  The Genomic Landscape of Mucinous Breast Cancer.

Authors:  Fresia Pareja; Ju Youn Lee; David N Brown; Salvatore Piscuoglio; Rodrigo Gularte-Mérida; Pier Selenica; Arnaud Da Cruz Paula; Sasi Arunachalam; Rahul Kumar; Felipe C Geyer; Catarina Silveira; Edaise M da Silva; Anqi Li; Caterina Marchiò; Charlotte K Y Ng; Odette Mariani; Laetitia Fuhrmann; Hannah Y Wen; Larry Norton; Anne Vincent-Salomon; Edi Brogi; Jorge S Reis-Filho; Britta Weigelt
Journal:  J Natl Cancer Inst       Date:  2019-07-01       Impact factor: 13.506

8.  Chordin-Like 1 Suppresses Bone Morphogenetic Protein 4-Induced Breast Cancer Cell Migration and Invasion.

Authors:  Chanèle Cyr-Depauw; Jason J Northey; Sébastien Tabariès; Matthew G Annis; Zhifeng Dong; Sean Cory; Michael Hallett; Jonathan P Rennhack; Eran R Andrechek; Peter M Siegel
Journal:  Mol Cell Biol       Date:  2016-05-02       Impact factor: 4.272

Review 9.  Emerging roles for LPP in metastatic cancer progression.

Authors:  Elaine Ngan; Alex Kiepas; Claire M Brown; Peter M Siegel
Journal:  J Cell Commun Signal       Date:  2017-10-13       Impact factor: 5.782

10.  PP2A binds to the LIM domains of lipoma-preferred partner through its PR130/B″ subunit to regulate cell adhesion and migration.

Authors:  Veerle Janssens; Karen Zwaenepoel; Carine Rossé; Marleen M R Petit; Jozef Goris; Peter J Parker
Journal:  J Cell Sci       Date:  2016-03-04       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.